Результаты поиска - Christianne Groeneveldt

  • Отображение 1 - 6 результаты of 6
Отмена результатов
  1. 1
    Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy?

    Preexisting immunity: Barrier or bridge to effective oncolytic virus therapy? по Christianne Groeneveldt, Jasper van den Ende, Nadine van Montfoort

    Опубликовано 2023
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor

    Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor по Flavia Fontana, Manlio Fusciello, Christianne Groeneveldt, Cristian Capasso, Jacopo Chiaro, Sara Feola, Zehua Liu, Ermei Mäkilä, Jarno Salonen, Jouni Hirvonen, Vincenzo Cerullo, Hélder A. Santos

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy

    Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy по Christianne Groeneveldt, Priscilla Kinderman, Diana J.M. van den Wollenberg, Ruben L van den Oever, Jim Middelburg, Dana A. M. Mustafa, Rob C. Hoeben, Sjoerd H. van der Burg, Thorbald van Hall, Nadine van Montfoort

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    <scp>NKG2A</scp> is a late immune checkpoint on <scp>CD8</scp> T cells and marks repeated stimulation and cell division

    <scp>NKG2A</scp> is a late immune checkpoint on <scp>CD8</scp> T cells and marks repeated stimulation and cell division по Linda Borst, Marjolein Sluijter, Gregor Sturm, Pornpimol Charoentong, Saskia J. Santegoets, Mandy van Gulijk, Marit J van Elsas, Christianne Groeneveldt, Nadine van Montfoort, Francesca Finotello, Zlatko Trajanoski, Szymon M. Kiełbasa, Sjoerd H. van der Burg, Thorbald van Hall

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors

    T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors по Jim Middelburg, Marjolein Sluijter, Gaby Schaap, Büşra Göynük, Katy A. Lloyd, Vitalijs Ovcinnikovs, Gijs G. Zom, Renoud J. Marijnissen, Christianne Groeneveldt, Lisa Griffioen, Gerwin W. Sandker, Sandra Heskamp, Sjoerd H. van der Burg, Tsolère Arakelian, Ferry Ossendorp, Ramon Arens, Janine Schuurman, Kristel Kemper, Thorbald van Hall

    Опубликовано 2024
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model

    Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model по Sai Ping Lau, Nadine van Montfoort, Priscilla Kinderman, Melanie Lukkes, Larissa Klaase, Menno van Nimwegen, Mandy van Gulijk, Jasper Dumas, Dana A. M. Mustafa, Sanne Lievense, Christianne Groeneveldt, Ralph Stadhouders, Yunlei Li, Andrew Stubbs, Koen A. Marijt, Heleen Vroman, Sjoerd H. van der Burg, Joachim G.J.V. Aerts, Thorbald van Hall, Floris Dammeijer, Casper H.J. van Eijck

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: